Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase 3 ALFA-0701 trial

Title
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase 3 ALFA-0701 trial
Authors
Keywords
-
Journal
HAEMATOLOGICA
Volume -, Issue -, Pages haematol.2018.188888
Publisher
Ferrata Storti Foundation (Haematologica)
Online
2018-08-03
DOI
10.3324/haematol.2018.188888

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation